← Back to Search

N/A

Collaborative multidisciplinary integrated care for Chronic Hepatitis C

N/A
Waitlist Available
Led By Brian R. Edlin, MD
Research Sponsored by Brian Edlin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up quarterly up to 10 years
Awards & highlights

Study Summary

The purpose of this study is to examine the feasibility, safety, and effectiveness of treating persons who are actively using illicit drugs for hepatitis C using a collaborative, multidisciplinary, integrated care model. We hypothesize that by maximizing facilitators and minimizing barriers to treatment we can enable drug users to receive effective treatment for hepatitis C.

Eligible Conditions
  • Chronic Hepatitis C
  • Substance Abuse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~quarterly up to 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and quarterly up to 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sustained virologic response, defined as an undetectable serum HCV RNA level 24 weeks after completion of antiviral therapy.
Secondary outcome measures
adherence to antiviral therapy
completion of antiviral therapy
completion of medical and psychiatric evaluation for antiviral therapy
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Collaborative multidisciplinary integrated careExperimental Treatment1 Intervention
Collaborative, multidisciplinary, integrated care for hepatitis C

Find a Location

Who is running the clinical trial?

State University of New York - Downstate Medical CenterOTHER
65 Previous Clinical Trials
12,521 Total Patients Enrolled
Brian EdlinLead Sponsor
Weill Medical College of Cornell UniversityOTHER
1,054 Previous Clinical Trials
1,316,498 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Hepatitis C Treatment in Underserved Populations
Brian Edlin 2005. "Hepatitis C Treatment in Underserved Populations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01717560.
All > Autoimmune Hepatitis > Hepatitis C
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top